Solid Biosciences Inc.
SLDB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$124,697 | -$96,015 | -$85,981 | -$72,188 |
| Dep. & Amort. | $2,455 | $2,581 | $2,408 | $2,964 |
| Deferred Tax | $0 | $0 | $0 | $1,209 |
| Stock-Based Comp. | $10,519 | $7,625 | $7,537 | $13,373 |
| Change in WC | $2,850 | -$6,337 | -$3,689 | -$23,041 |
| Other Non-Cash | $8,861 | -$2,034 | -$18,252 | -$81 |
| Operating Cash Flow | -$100,012 | -$94,180 | -$97,977 | -$77,764 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$654 | -$1,515 | -$3,015 | -$1,281 |
| Net Acquisitions | $5 | $0 | $31,523 | $89,805 |
| Inv. Purchases | -$204,337 | -$117,428 | -$182,762 | -$141,249 |
| Inv. Sales/Matur. | $188,900 | $128,632 | $212,811 | $51,444 |
| Other Inv. Act. | $0 | $0 | $600 | -$89,805 |
| Investing Cash Flow | -$16,086 | $9,689 | $59,157 | -$91,086 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$473 | $0 | $2,077 | $0 |
| Stock Issued | $127,227 | $2,974 | $72,551 | $134,878 |
| Stock Repurch. | -$5,111 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $794 | $148 | $203 | $107 |
| Financing Cash Flow | $122,437 | $3,122 | $74,831 | $134,985 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $6,339 | -$81,369 | $36,011 | -$33,865 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $75,848 | $155,384 | $121,206 | $155,071 |
| End Cash | $82,187 | $74,015 | $157,217 | $121,206 |
| Free Cash Flow | -$100,666 | -$95,695 | -$100,992 | -$79,045 |